The Archive · A Source

Improved survival of autologous stem cell transplantation in primary refractory and relapsed Hodgkin lymphoma in the brentuximab vedotin era

PMC/BMT Journal August 2023 www.ncbi.nlm.nih.gov/pmc/articles/PMC10444678